749 related articles for article (PubMed ID: 23423669)
1. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
Reetz K; Costa AS; Mirzazade S; Lehmann A; Juzek A; Rakowicz M; Boguslawska R; Schöls L; Linnemann C; Mariotti C; Grisoli M; Dürr A; van de Warrenburg BP; Timmann D; Pandolfo M; Bauer P; Jacobi H; Hauser TK; Klockgether T; Schulz JB;
Brain; 2013 Mar; 136(Pt 3):905-17. PubMed ID: 23423669
[TBL] [Abstract][Full Text] [Related]
2. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
Schulz JB; Borkert J; Wolf S; Schmitz-Hübsch T; Rakowicz M; Mariotti C; Schöls L; Timmann D; van de Warrenburg B; Dürr A; Pandolfo M; Kang JS; Mandly AG; Nägele T; Grisoli M; Boguslawska R; Bauer P; Klockgether T; Hauser TK
Neuroimage; 2010 Jan; 49(1):158-68. PubMed ID: 19631275
[TBL] [Abstract][Full Text] [Related]
3. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias.
Della Nave R; Foresti S; Tessa C; Moretti M; Ginestroni A; Gavazzi C; Guerrini L; Salvi F; Piacentini S; Mascalchi M
Neuroimage; 2004 Jun; 22(2):698-705. PubMed ID: 15193598
[TBL] [Abstract][Full Text] [Related]
4. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study.
Guerrini L; Lolli F; Ginestroni A; Belli G; Della Nave R; Tessa C; Foresti S; Cosottini M; Piacentini S; Salvi F; Plasmati R; De Grandis D; Siciliano G; Filla A; Mascalchi M
Brain; 2004 Aug; 127(Pt 8):1785-95. PubMed ID: 15240431
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of grey and white matter reduction in spinocerebellar ataxia type 3 and 6: a voxel-based morphometry study.
Lukas C; Schöls L; Bellenberg B; Rüb U; Przuntek H; Schmid G; Köster O; Suchan B
Neurosci Lett; 2006 Nov; 408(3):230-5. PubMed ID: 17005321
[TBL] [Abstract][Full Text] [Related]
6. Gray matter volume deficits in spinocerebellar ataxia: an optimized voxel based morphometric study.
Goel G; Pal PK; Ravishankar S; Venkatasubramanian G; Jayakumar PN; Krishna N; Purushottam M; Saini J; Faruq M; Mukherji M; Jain S
Parkinsonism Relat Disord; 2011 Aug; 17(7):521-7. PubMed ID: 21600833
[TBL] [Abstract][Full Text] [Related]
7. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
[TBL] [Abstract][Full Text] [Related]
8. Patterns of fractional anisotropy changes in white matter of cerebellar peduncles distinguish spinocerebellar ataxia-1 from multiple system atrophy and other ataxia syndromes.
Prakash N; Hageman N; Hua X; Toga AW; Perlman SL; Salamon N
Neuroimage; 2009 Aug; 47 Suppl 2():T72-81. PubMed ID: 19446636
[TBL] [Abstract][Full Text] [Related]
9. Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17).
Lasek K; Lencer R; Gaser C; Hagenah J; Walter U; Wolters A; Kock N; Steinlechner S; Nagel M; Zühlke C; Nitschke MF; Brockmann K; Klein C; Rolfs A; Binkofski F
Brain; 2006 Sep; 129(Pt 9):2341-52. PubMed ID: 16760196
[TBL] [Abstract][Full Text] [Related]
10. Gray and white matter alterations in spinocerebellar ataxia type 7: an in vivo DTI and VBM study.
Alcauter S; Barrios FA; Díaz R; Fernández-Ruiz J
Neuroimage; 2011 Mar; 55(1):1-7. PubMed ID: 21147232
[TBL] [Abstract][Full Text] [Related]
11. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
[TBL] [Abstract][Full Text] [Related]
12. Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics.
Della Nave R; Ginestroni A; Tessa C; Salvatore E; De Grandis D; Plasmati R; Salvi F; De Michele G; Dotti MT; Piacentini S; Mascalchi M
Neuroimage; 2008 Oct; 43(1):10-9. PubMed ID: 18672073
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich's ataxia.
Stefanescu MR; Dohnalek M; Maderwald S; Thürling M; Minnerop M; Beck A; Schlamann M; Diedrichsen J; Ladd ME; Timmann D
Brain; 2015 May; 138(Pt 5):1182-97. PubMed ID: 25818870
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestation, imaging, and genotype analysis of two pedigrees with spinocerebellar ataxia.
Peipei L; Yang L; Weihong G; Xiaonan S
Cell Biochem Biophys; 2011 Dec; 61(3):691-8. PubMed ID: 21739264
[TBL] [Abstract][Full Text] [Related]
15. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
[TBL] [Abstract][Full Text] [Related]
16. Spinocerebellar ataxia type 1 (SCA1): new pathoanatomical and clinico-pathological insights.
Rüb U; Bürk K; Timmann D; den Dunnen W; Seidel K; Farrag K; Brunt E; Heinsen H; Egensperger R; Bornemann A; Schwarzacher S; Korf HW; Schöls L; Bohl J; Deller T
Neuropathol Appl Neurobiol; 2012 Dec; 38(7):665-80. PubMed ID: 22309224
[TBL] [Abstract][Full Text] [Related]
17. Brain structural damage in spinocerebellar ataxia type 2. A voxel-based morphometry study.
Della Nave R; Ginestroni A; Tessa C; Cosottini M; Giannelli M; Salvatore E; Sartucci F; De Michele G; Dotti MT; Piacentini S; Mascalchi M
Mov Disord; 2008 Apr; 23(6):899-903. PubMed ID: 18311829
[TBL] [Abstract][Full Text] [Related]
18. Pontine atrophy precedes cerebellar degeneration in spinocerebellar ataxia 7: MRI-based volumetric analysis.
Bang OY; Lee PH; Kim SY; Kim HJ; Huh K
J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1452-6. PubMed ID: 15377695
[TBL] [Abstract][Full Text] [Related]
19. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
[TBL] [Abstract][Full Text] [Related]
20. Spinocerebellar ataxia type 2 (SCA2) with white matter involvement.
Armstrong J; Bonaventura I; Rojo A; González G; Corral J; Nadal N; Volpini V; Ferrer I
Neurosci Lett; 2005 Jun; 381(3):247-51. PubMed ID: 15896478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
